| __timestamp | Ionis Pharmaceuticals, Inc. | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20140000 | 72429000 |
| Thursday, January 1, 2015 | 37173000 | 78634000 |
| Friday, January 1, 2016 | 48616000 | 75374000 |
| Sunday, January 1, 2017 | 108488000 | 92157000 |
| Monday, January 1, 2018 | 244622000 | 93326000 |
| Tuesday, January 1, 2019 | 287000000 | 103132000 |
| Wednesday, January 1, 2020 | 354000000 | 110171000 |
| Friday, January 1, 2021 | 186000000 | 218817000 |
| Saturday, January 1, 2022 | 151000000 | 233827000 |
| Sunday, January 1, 2023 | 232600000 | 267194000 |
| Monday, January 1, 2024 | 267474000 |
Unleashing insights
In the competitive world of biotechnology, managing expenses is crucial for sustaining growth and innovation. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Lantheus Holdings, Inc. and Ionis Pharmaceuticals, Inc. over the past decade. From 2014 to 2023, Ionis Pharmaceuticals saw a staggering 1,000% increase in SG&A expenses, peaking in 2020. Meanwhile, Lantheus Holdings experienced a more modest 270% rise, with a notable surge in 2023. This divergence highlights differing strategic priorities: Ionis's aggressive expansion versus Lantheus's steady growth. As the biotech sector evolves, understanding these financial trends offers valuable insights into each company's operational focus and market positioning. Investors and industry analysts should consider these patterns when evaluating future prospects and competitive dynamics.
Who Optimizes SG&A Costs Better? Merck & Co., Inc. or Lantheus Holdings, Inc.
Biogen Inc. vs Ionis Pharmaceuticals, Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Lantheus Holdings, Inc.
Catalent, Inc. or Ionis Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Halozyme Therapeutics, Inc. vs Ionis Pharmaceuticals, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs Cytokinetics, Incorporated
Cost Management Insights: SG&A Expenses for Lantheus Holdings, Inc. and Corcept Therapeutics Incorporated
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs PTC Therapeutics, Inc.
Comparing SG&A Expenses: Lantheus Holdings, Inc. vs Celldex Therapeutics, Inc. Trends and Insights
Ionis Pharmaceuticals, Inc. vs Opthea Limited: SG&A Expense Trends
Ionis Pharmaceuticals, Inc. vs Merus N.V.: SG&A Expense Trends
Ionis Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.: SG&A Spending Patterns Compared